X-155116702-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001018055.3(BRCC3):c.681-9A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 1,166,423 control chromosomes in the GnomAD database, including 34 homozygotes. There are 640 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.012 ( 20 hom., 348 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 14 hom. 292 hem. )
Consequence
BRCC3
NM_001018055.3 splice_polypyrimidine_tract, intron
NM_001018055.3 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00001907
2
Clinical Significance
Conservation
PhyloP100: -0.641
Genes affected
BRCC3 (HGNC:24185): (BRCA1/BRCA2-containing complex subunit 3) This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This complex plays a role in the DNA damage response, where it is responsible for the stable accumulation of BRCA1 at DNA break sites. The component encoded by this gene can specifically cleave Lys 63-linked polyubiquitin chains, and it regulates the abundance of these polyubiquitin chains in chromatin. The loss of this gene results in abnormal angiogenesis and is associated with syndromic moyamoya, a cerebrovascular angiopathy. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jun 2011]
MTCP1 (HGNC:7423): (mature T cell proliferation 1) This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-155116702-A-G is Benign according to our data. Variant chrX-155116702-A-G is described in ClinVar as [Benign]. Clinvar id is 710187.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.012 (1352/112300) while in subpopulation AFR AF= 0.0406 (1254/30914). AF 95% confidence interval is 0.0387. There are 20 homozygotes in gnomad4. There are 348 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRCC3 | NM_001018055.3 | c.681-9A>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000330045.12 | NP_001018065.1 | |||
BRCC3 | NM_001242640.2 | c.684-9A>G | splice_polypyrimidine_tract_variant, intron_variant | NP_001229569.1 | ||||
BRCC3 | NM_024332.4 | c.756-9A>G | splice_polypyrimidine_tract_variant, intron_variant | NP_077308.1 | ||||
BRCC3 | XM_005274751.5 | c.759-9A>G | splice_polypyrimidine_tract_variant, intron_variant | XP_005274808.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRCC3 | ENST00000330045.12 | c.681-9A>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001018055.3 | ENSP00000328641 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1350AN: 112246Hom.: 20 Cov.: 23 AF XY: 0.0101 AC XY: 346AN XY: 34418
GnomAD3 genomes
AF:
AC:
1350
AN:
112246
Hom.:
Cov.:
23
AF XY:
AC XY:
346
AN XY:
34418
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00333 AC: 458AN: 137596Hom.: 4 AF XY: 0.00206 AC XY: 84AN XY: 40838
GnomAD3 exomes
AF:
AC:
458
AN:
137596
Hom.:
AF XY:
AC XY:
84
AN XY:
40838
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1162AN: 1054123Hom.: 14 Cov.: 24 AF XY: 0.000873 AC XY: 292AN XY: 334429
GnomAD4 exome
AF:
AC:
1162
AN:
1054123
Hom.:
Cov.:
24
AF XY:
AC XY:
292
AN XY:
334429
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0120 AC: 1352AN: 112300Hom.: 20 Cov.: 23 AF XY: 0.0101 AC XY: 348AN XY: 34482
GnomAD4 genome
AF:
AC:
1352
AN:
112300
Hom.:
Cov.:
23
AF XY:
AC XY:
348
AN XY:
34482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at